PMID: 9539787May 16, 1998Paper

Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol

Proceedings of the National Academy of Sciences of the United States of America
M L VarbanD Huszar

Abstract

Scavenger receptor BI (SR-BI) is a cell surface receptor that binds high density lipoproteins (HDL) and mediates selective uptake of HDL cholesteryl esters (CE) in transfected cells. To address the physiological role of SR-BI in HDL cholesterol homeostasis, mice were generated bearing an SR-BI promoter mutation that resulted in decreased expression of the receptor in homozygous mutant (designated SR-BI att) mice. Hepatic expression of the receptor was reduced by 53% with a corresponding increase in total plasma cholesterol levels of 50-70% in SR-BI att mice, attributable almost exclusively to elevated plasma HDL. In addition to increased HDL-CE, HDL phospholipids and apo A-1 levels were elevated, and there was an increase in HDL particle size in mutant mice. Metabolic studies using HDL bearing nondegradable radiolabels in both the protein and lipid components demonstrated that reducing hepatic SR-BI expression by half was associated with a decrease of 47% in selective uptake of CE by the liver, and a corresponding reduction of 53% in selective removal of HDL-CE from plasma. Taken together, these findings strongly support a pivotal role for hepatic SR-BI expression in regulating plasma HDL levels and indicate that SR-BI is the m...Continue Reading

References

Jan 1, 1992·Annual Review of Immunology·B H Koller, O Smithies
Jul 1, 1992·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·B M RichardR C Pittman
Oct 25, 1991·Nucleic Acids Research·M W McBurneyK Jardine
Nov 9, 1989·The New England Journal of Medicine·D J Gordon, B M Rifkind
Jan 1, 1986·Methods in Enzymology·R C Pittman, C A Taylor
Apr 4, 1986·Science·M S Brown, J L Goldstein
Jan 1, 1986·Methods in Enzymology·N A LeW V Brown
Oct 1, 1993·Current Opinion in Biotechnology·B Morrow, R Kucherlapati
Aug 22, 1997·The Journal of Biological Chemistry·Y JiA R Tall
Nov 14, 1997·Proceedings of the National Academy of Sciences of the United States of America·A RigottiM Krieger

❮ Previous
Next ❯

Citations

Dec 21, 2000·Current Atherosclerosis Reports·M A KawashiriD J Rader
Dec 21, 2000·Current Atherosclerosis Reports·V S Kamanna, M L Kashyap
Jun 14, 2006·Current Atherosclerosis Reports·Atif Qasim, Daniel J Rader
Sep 6, 2003·The American Journal of Cardiology·Daniel J Rader
Mar 13, 2002·Atherosclerosis·Dmitri Sviridov, Paul Nestel
Jul 17, 1999·Atherosclerosis·O Stein, Y Stein
Apr 9, 2001·Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie·F MilliatC Lutton
Nov 1, 2003·The International Journal of Biochemistry & Cell Biology·David Rhainds, Louise Brissette
Nov 24, 1999·Molecular Medicine Today·S L ActonA Rigotti
Dec 9, 2000·Biochimica Et Biophysica Acta·S YamashitaY Matsuzawa
Apr 2, 1999·Biochimica Et Biophysica Acta·R de CromA van der Kamp
Apr 27, 1999·Biochimica Et Biophysica Acta·L Liscum, N J Munn
Jun 8, 2010·Nature Neuroscience·Diego Perez-TilveMatthias H Tschöp
Nov 16, 2010·Proceedings of the National Academy of Sciences of the United States of America·Kalliopi ThanopoulouSpiros Georgopoulos
Nov 6, 2009·Antioxidants & Redox Signaling·Irena LevitanPapasani V Subbaiah
Aug 25, 2009·Human Reproduction Update·Victor Y FujimotoRichard W Browne
May 17, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Gunter WolfFranz Rinninger
Oct 7, 2006·Current Opinion in Gastroenterology·S J Karpen, J M Crawford
Oct 13, 2006·Current Opinion in Gastroenterology·Hideyuki HyogoDavid E Cohen
Nov 13, 1998·Current Opinion in Lipidology
Mar 13, 1999·Current Opinion in Lipidology·T Seo, R J Deckelbaum
Sep 11, 1999·Current Opinion in Lipidology·D L WilliamsG H Rothblat
Feb 19, 2000·Current Opinion in Lipidology·M Krieger, K Kozarsky
Apr 29, 2000·Current Opinion in Lipidology·B TrigattiM Krieger
Sep 19, 2001·Current Opinion in Lipidology·D L Silver, A R Tall
May 29, 2004·Current Opinion in Lipidology·Margery A Connelly, David L Williams
May 14, 2005·Current Opinion in Lipidology·Miranda Van EckTheo Jc Van Berkel
Aug 22, 2012·Current Opinion in Lipidology·Chieko Mineo, Philip W Shaul
Jan 30, 2009·Diabetes, Obesity & Metabolism·K C B Tan
Oct 10, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·David MassonAlan R Tall
Dec 19, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Marina CuchelDaniel J Rader
Jul 18, 2001·The Journal of Clinical Investigation·B L VaismanS Santamarina-Fojo

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.